5 news items
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI
21 May 24
strategy that impacts study protocols, subject recruitment profiles, user-related risk analyses, and patient-centered considerations aimed at optimizing care
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
ME
PTPI
14 May 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether in the negative
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
ME
PTPI
14 May 24
or incorporated in this press release, including statements regarding 23andMe's strategy, are forward-looking statements. The words "believes
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
PTPI
23 Apr 24
," "pursuit," "strategy" and similar expressions, whether in the negative or affirmative, that reflect our current views with respect
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
PTPI
16 Apr 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether
- Prev
- 1
- Next